Tromantadine: Difference between revisions

Jump to navigation Jump to search
m (Protected "Tromantadine": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
 
No edit summary
Line 1: Line 1:
{{Drugbox|
{{Drugbox
|IUPAC_name = ''N''-1-adamantyl-''N''-[2-(dimethylamino)ethoxy]acetamide
| Verifiedfields = changed
| image = Tromantadine.png
| Watchedfields = changed
| CAS_number=53783-83-8
| verifiedrevid = 470617884
| ATC_prefix=D06
| IUPAC_name = ''N''-1-adamantyl-''N''-[2-(dimethylamino)ethoxy]acetamide
| ATC_suffix=BB02  
| image = Tromantadine2DCSD.svg
| PubChem=64377
| alt = Skeletal formula
| DrugBank=
| image2 = Tromantadine-3D-balls.png
| C = 16 |H = 28 |N = 2 |O = 2
| alt2 = Ball-and-stick model
<!--Clinical data-->
| tradename = 
| Drugs.com = {{drugs.com|international|tromantadine}}
| pregnancy_category = 
| legal_status = 
| routes_of_administration = [[Topical]]
 
<!--Pharmacokinetic data-->
| bioavailability = 
| metabolism = 
| excretion = 
 
<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 53783-83-8
| ATC_prefix = D06
| ATC_suffix = BB02
| ATC_supplemental = {{ATC|J05|AC03}}
| PubChem = 64377
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 57947
| NIAID_ChemDB = 007760
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = H191JFG8WA
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07199
 
<!--Chemical data-->
| C=16 | H=28 | N=2 | O=2  
| molecular_weight = 280.406 [[Gram|g]]/[[Mole (unit)|mol]]
| molecular_weight = 280.406 [[Gram|g]]/[[Mole (unit)|mol]]
| smiles = O=C(C)N(OCCN(C)C)C23CC1CC(C3)CC(C2)C1
| smiles = O=C(NC13CC2CC(CC(C1)C2)C3)COCCN(C)C
| bioavailability=  
| InChI = 1/C16H28N2O2/c1-18(2)3-4-20-11-15(19)17-16-8-12-5-13(9-16)7-14(6-12)10-16/h12-14H,3-11H2,1-2H3,(H,17,19)
| metabolism =  
| InChIKey = UXQDWARBDDDTKG-UHFFFAOYAP
| elimination_half-life=
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| excretion =
| StdInChI = 1S/C16H28N2O2/c1-18(2)3-4-20-11-15(19)17-16-8-12-5-13(9-16)7-14(6-12)10-16/h12-14H,3-11H2,1-2H3,(H,17,19)
| pregnancy_category =
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| legal_status =
| StdInChIKey = UXQDWARBDDDTKG-UHFFFAOYSA-N
| routes_of_administration= [[Topical]]
}}
}}
'''Tromantadine''' is an [[antiviral]] [[medicine]] used to treat [[herpes simplex virus]]. It is available in a topical [[gel]] under trade name '''Viru-Merz'''. Its performance is similar to [[aciclovir]].
'''Tromantadine''' is an [[antiviral medicine]] used to treat [[herpes simplex virus]]. It is available in a topical [[gel]] under trade name '''Viru-Merz'''. Its performance is similar to [[aciclovir]].
 
Like [[rimantadine]] and [[amantadine]], tromantadine is a derivative of [[adamantane]].


Tromantadine inhibits the early and late events in the [[virus]] replication cycle. It changes the [[glycoprotein]]s of the host cells, therefore impeding the absorption of the virus. It inhibits penetration of the virus. It also prevents [[uncoating]] of the [[virion]]s.
==Mechanism==
Tromantadine inhibits the early and late events in the [[virus]] replication cycle.<ref name="pmid6297383">{{cite journal |author=Rosenthal KS, Sokol MS, Ingram RL, Subramanian R, Fort RC |title=Tromantadine: inhibitor of early and late events in herpes simplex virus replication |journal=Antimicrob. Agents Chemother. |volume=22 |issue=6 |pages=1031–6 |date=December 1982 |pmid=6297383 |pmc=185716 |doi= 10.1128/aac.22.6.1031|url=http://aac.asm.org/cgi/pmidlookup?view=long&pmid=6297383}}</ref> It changes the [[glycoprotein]]s of the host cells, therefore impeding the absorption of the virus. It inhibits penetration of the virus. It also prevents [[uncoating]] of the [[virion]]s.


Like [[rimantadine]] and [[amantadine]], tromantadine is a derivative of [[adamantane]].
==References==
{{reflist}}


==External links==
==External links==
*[http://www.brookespharma.com/brands_virumerz_main.htm Viru-Merz website]
*[http://www.brookespharma.com/brands_virumerz_main.htm Viru-Merz website]


{{antimicrobial-stub}}
{{Antibiotics and chemotherapeutics for dermatological use}}
{{Antibiotics and chemotherapeutics for dermatological use}}
{{Antivirals}}
{{Antivirals}}
[[Category:Antivirals]]
[[Category:Anti-herpes virus drugs]]
[[Category:Adamantanes]]
[[Category:Acetamides]]
[[Category:Amines]]
 
 
{{antiinfective-drug-stub}}
{{dermatologic-drug-stub}}

Revision as of 15:09, 10 April 2015

Tromantadine
Skeletal formula
Ball-and-stick model
Clinical data
AHFS/Drugs.comInternational Drug Names
Routes of
administration
Topical
ATC code
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
NIAID ChemDB
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC16H28N2O2
Molar mass280.406 g/mol
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

Tromantadine is an antiviral medicine used to treat herpes simplex virus. It is available in a topical gel under trade name Viru-Merz. Its performance is similar to aciclovir.

Like rimantadine and amantadine, tromantadine is a derivative of adamantane.

Mechanism

Tromantadine inhibits the early and late events in the virus replication cycle.[1] It changes the glycoproteins of the host cells, therefore impeding the absorption of the virus. It inhibits penetration of the virus. It also prevents uncoating of the virions.

References

  1. Rosenthal KS, Sokol MS, Ingram RL, Subramanian R, Fort RC (December 1982). "Tromantadine: inhibitor of early and late events in herpes simplex virus replication". Antimicrob. Agents Chemother. 22 (6): 1031–6. doi:10.1128/aac.22.6.1031. PMC 185716. PMID 6297383.

External links


Template:Antiinfective-drug-stub Template:Dermatologic-drug-stub